Neurocrine Biosciences (NBIX) Liabilities and Shareholders Equity (2010 - 2026)
Neurocrine Biosciences' Liabilities and Shareholders Equity came in at $5.36 billion for Q2 2026, up 37.8% from $3.89 billion a year earlier and up 9.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences' Liabilities and Shareholders Equity was $4.63 billion, up 24.5% from FY2024.
- Liabilities and Shareholders Equity has increased in each of the last nine years, with a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $3.72 billion in FY2024 (+14.4%), $3.25 billion in FY2023 (+37.3%), $2.37 billion in FY2022 (+14.3%) and $2.07 billion in FY2021 (+19.5%).
- The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
- Year-over-year, Liabilities and Shareholders Equity has increased for 37 consecutive quarters, with growth averaging 22.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Liabilities and Shareholders Equity ran from 2.5% in Q2 2022 to 47.1% in Q1 2024.
- Business Quant data shows NBIX's Liabilities and Shareholders Equity at $4.91 billion (Q1 2026), $4.63 billion (Q4 2025) and $4.27 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 5.36 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.36 Bn |
| Mar 31, 2026 | 4.91 Bn |
| Dec 31, 2025 | 4.63 Bn |
| Sep 30, 2025 | 4.27 Bn |
| Jun 30, 2025 | 3.89 Bn |
| Mar 31, 2025 | 3.69 Bn |
| Dec 31, 2024 | 3.72 Bn |
| Sep 30, 2024 | 3.54 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 3.47 Bn |
| Dec 31, 2023 | 3.25 Bn |
| Sep 30, 2023 | 2.85 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | 2.36 Bn |
| Dec 31, 2022 | 2.37 Bn |
| Sep 30, 2022 | 2.14 Bn |
| Jun 30, 2022 | 2.01 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 2.07 Bn |
| Sep 30, 2021 | 2.02 Bn |
API Access
Neurocrine Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();